The detailed information for PTAB case with proceeding number IPR2025-01346 filed by BPI Labs, LLC et al. on Aug 4, 2025. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2025-01346
Filing Date
Aug 4, 2025
Petitioner
BPI Labs, LLC et al.
Status
Petition filed
Respondent Application Number
14987791
Respondent Tech Center
1600
Respondent Patent Number
9474780

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

EX1001-US Patent US9474780B2

Aug 4, 2025EXHIBITPETITIONER

EX1002-Declaration Dr. Virginia Cornish

Aug 4, 2025EXHIBITPETITIONER

EX1004-Prosecution History US Patent 9474780

Aug 4, 2025EXHIBITPETITIONER

EX1005-International Search Report

Aug 4, 2025EXHIBITPETITIONER

EX1006-Written Opinion

Aug 4, 2025EXHIBITPETITIONER

EX1007-WO2011-119657 A1

Aug 4, 2025EXHIBITPETITIONER

EX1008-WO2013-164483 A1

Aug 4, 2025EXHIBITPETITIONER

EX1009-WO2006-097537 A2

Aug 4, 2025EXHIBITPETITIONER

EX1010-WO2014-202727 A1

Aug 4, 2025EXHIBITPETITIONER

EX1011-Article- Introduction to Peptide Synthesis

Aug 4, 2025EXHIBITPETITIONER

EX1012-US Patent Application Publication

Aug 4, 2025EXHIBITPETITIONER

EX1013-Article- Injection Drug Label(SAXENDA)

Aug 4, 2025EXHIBITPETITIONER

EX1014-Article- Lehninger Principles of Biochemistry

Aug 4, 2025EXHIBITPETITIONER

EX1015-Article- Hormones and their Actions Part 1

Aug 4, 2025EXHIBITPETITIONER

EX1016-Article-Pyrrolsysine and Selencysteine

Aug 4, 2025EXHIBITPETITIONER

EX1018-The synthesis of a tetrapeptide

Aug 4, 2025EXHIBITPETITIONER

EX1019-Article- Synthetic Analogs of Oxytocin and the Vasopressins

Aug 4, 2025EXHIBITPETITIONER

EX1020 - Keen_Human Insulin Produced

Aug 4, 2025EXHIBITPETITIONER

EX1021 - Karten_Gonadotropin-releasing hormone

Aug 4, 2025EXHIBITPETITIONER

EX1022 - Garay_Antibodies against polyethylene

Aug 4, 2025EXHIBITPETITIONER

EX1023 - Knudsen_the therapeutic promise from animal models

Aug 4, 2025EXHIBITPETITIONER

EX1024 - Ward_Peptide lipidation stabilizes structure

Aug 4, 2025EXHIBITPETITIONER

EX1025 - Zhang_Converting peptides into drug leads

Aug 4, 2025EXHIBITPETITIONER

EX1026-Article- Synthetic Molecular Evolution of Pore-Forming Peptides

Aug 4, 2025EXHIBITPETITIONER

EX1027-Article-New Type of Synthetic peptide library

Aug 4, 2025EXHIBITPETITIONER

EX1028 - Liu_Article-High-Througout Screening of One-Bead-One-Compound L

Aug 4, 2025EXHIBITPETITIONER

EX1029-Article-GPCR structures in drug design

Aug 4, 2025EXHIBITPETITIONER

EX1030-Reviews-The structure and function of the glucagon

Aug 4, 2025EXHIBITPETITIONER

EX1031-Reviews-Teaching old receptors new tricks

Aug 4, 2025EXHIBITPETITIONER

EX1032-Article-New insights into the role of Camp in the production and fun

Aug 4, 2025EXHIBITPETITIONER

EX1033-Article-Functional Consequences of Glucagon

Aug 4, 2025EXHIBITPETITIONER

EX1034-Article-Beta-Arrestin2

Aug 4, 2025EXHIBITPETITIONER

EX1035-Oxyntomodulin Differentially Affects Glucago

Aug 4, 2025EXHIBITPETITIONER

EX1036 - Sonoda_Article - B-Arrestin-1 mediates glucagon-like peptide-1 sig

Aug 4, 2025EXHIBITPETITIONER

EX1037-Article-Structure of the human glucagon class BG-protein

Aug 4, 2025EXHIBITPETITIONER

EX1038-Article-Mechanisms of peptide and nonpeptide ligand binding to Class

Aug 4, 2025EXHIBITPETITIONER

EX1039-Article - Allosteric Modulators of Class B G-Protein

Aug 4, 2025EXHIBITPETITIONER

EX1040-Article-GIP and GLP-1 two incretin hormones

Aug 4, 2025EXHIBITPETITIONER

EX1041-Article-Further Purification of Polypeptide Demonstrating Enterogast

Aug 4, 2025EXHIBITPETITIONER

EX1042-Article-Gastric Inhibitory Polypeptide Structure and Chromosomal

Aug 4, 2025EXHIBITPETITIONER

EX1043-Article-Stimulation of Insulin Secretion

Aug 4, 2025EXHIBITPETITIONER

EX1044-Article-Pancreatic- Polypeptide Glucagon and Insulin Secretion

Aug 4, 2025EXHIBITPETITIONER

EX1045-Article_LUND Pancreatic preproglucagon cDNA contains two glucagon re

Aug 4, 2025EXHIBITPETITIONER

EX1046-Article - The short half-life of glucagon

Aug 4, 2025EXHIBITPETITIONER

EX1047-Article-Novel mechanism of actions

Aug 4, 2025EXHIBITPETITIONER

EX1048-Kieffer_Article-Degradation of Glucose-Dependent Insulinotropic Poly

Aug 4, 2025EXHIBITPETITIONER

EX1049-Article - High Potency Antagonists of the Pancreatic Glucagon

Aug 4, 2025EXHIBITPETITIONER

EX1050-Article-Injection Drug label - (VICTOZA)

Aug 4, 2025EXHIBITPETITIONER

EX1051-Article - Liraglutide_ A Review of the First Once -Daily GLP-1 Recep

Aug 4, 2025EXHIBITPETITIONER

EX1052-Article - Liraglutide-A Once Daily Incretin Mimetic for the Treatmen

Aug 4, 2025EXHIBITPETITIONER

EX1053-Article - Injection drug label (BYDUEREON)

Aug 4, 2025EXHIBITPETITIONER

EX1054-Article - Injection Drug Label (BYETTA)

Aug 4, 2025EXHIBITPETITIONER

EX1055-Article-Injection drug label (TRULICITY)

Aug 4, 2025EXHIBITPETITIONER

EX1056-Article-Injection Drug Label (ADLYXIN)

Aug 4, 2025EXHIBITPETITIONER

EX1057- Article -Injection Drug Label -(Ozempic)

Aug 4, 2025EXHIBITPETITIONER

EX1058-Article - Effect of Glucagon-Like Peptide-1 Receptor Agonists on Bod

Aug 4, 2025EXHIBITPETITIONER

EX1059-Article- A new glucagon and GLP-1 Co-agonist eliminates obesity

Aug 4, 2025EXHIBITPETITIONER

EX1060-Article - Glucagon-Like Peptide 1_Glucagon Receptor Dual Agonism Rev

Aug 4, 2025EXHIBITPETITIONER

EX1061-Article-Unimolecular Dual Incretins maximize metabolic Benefits

Aug 4, 2025EXHIBITPETITIONER

EX1062-Article - Crystal structure of Rhodospin_A G-Protein-Coupled Recepto

Aug 4, 2025EXHIBITPETITIONER

EX1063-Article- Crystal Structure of the human B2 adrenergic G-Protein-coup

Aug 4, 2025EXHIBITPETITIONER

EX1064 - Article-GPCR Network A large-scale collaboration

Aug 4, 2025EXHIBITPETITIONER

EX1065-Article - Protein Data Bank

Aug 4, 2025EXHIBITPETITIONER

EX1066-Article Biological Activities of Glucagon Like Peptide 1

Aug 4, 2025EXHIBITPETITIONER

EX1067-Article - Structure-Activity Studies of Glucagon-like Peptide -1

Aug 4, 2025EXHIBITPETITIONER

EX1068-Article - Glucagon-like Peptide-1 (GLP-1)

Aug 4, 2025EXHIBITPETITIONER

EX1069-Article-Endoproteolysis by isolated membrane peptidases

Aug 4, 2025EXHIBITPETITIONER

EX1070-Article-Clinical relevance of anti-exenatide antibodies

Aug 4, 2025EXHIBITPETITIONER

EX1071-Article - Liraglutide Treatment is Associated with a low frequency

Aug 4, 2025EXHIBITPETITIONER

EX1072- Doyle_C-terminal sequence

Aug 4, 2025EXHIBITPETITIONER

EX1073- Simonsen_C-terminal Extension

Aug 4, 2025EXHIBITPETITIONER

EX1074 - Tatarkiewicz_Article - A novel long-acting glucose-dependent

Aug 4, 2025EXHIBITPETITIONER

EX1075 - WO2015-067715-A2

Aug 4, 2025EXHIBITPETITIONER

EX1076 - Lorenz

Aug 4, 2025EXHIBITPETITIONER

EX1078 - Karp - Textbook Excerpts

Aug 4, 2025EXHIBITPETITIONER

EX1079 - Madsen_2007

Aug 4, 2025EXHIBITPETITIONER

EX1080 - IPR2025-01024 Petition

Aug 4, 2025EXHIBITPETITIONER

EX1082 - Runge

Aug 4, 2025EXHIBITPETITIONER

EX1083 - Torekov

Aug 4, 2025EXHIBITPETITIONER

EX1084 - Dr. Zhou Declaration

Aug 4, 2025EXHIBITPETITIONER

EX1085 - Sunny Zhou CV 2025-07-16

Aug 4, 2025EXHIBITPETITIONER

EX1017 - WO2010011439A2

Aug 4, 2025EXHIBITPETITIONER

Notice: Power of Attorney

Aug 4, 2025PAPERPETITIONER

Petition: as filed

Aug 4, 2025PAPERPETITIONER